Eleven Biotherapeutics Inc. (EBIO) Trading Down 5.9%
Eleven Biotherapeutics Inc. (NASDAQ:EBIO)’s share price was down 5.9% during mid-day trading on Friday . The stock traded as low as $3.80 and last traded at $4.11, with a volume of 3,013,986 shares trading hands. The stock had previously closed at $4.37.
The firm’s market capitalization is $61.11 million. The stock’s 50-day moving average is $2.41 and its 200 day moving average is $1.15.
In other news, major shareholder Boxer Capital, Llc sold 1,042,000 shares of the business’s stock in a transaction that occurred on Monday, June 13th. The shares were sold at an average price of $2.74, for a total value of $2,855,080.00. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link.
Eleven Biotherapeutics, Inc is a clinical-stage biopharmaceutical company. The Company through AMP-Rx, a protein engineering platform, is engaged in the discovery and development of protein therapeutics to treat diseases of the eye. The Company designs, engineers and generates a pipeline of protein therapeutic candidates that target cytokines, which are central to diseases of the eye.
Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.